It is possible they are running out of cash and do not have the money to pay for the rest of the deal. This is the only way of faulting on the deal. So the recent capital raising was for?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ASX Market Open: Futures say drop after Bullock's hawkish speech removes slow cut doubts | Nov 29, 2024